Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Environmental Biomarker Start-Up Gains $16M in Early Funds

Human body hair sample

A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds

CEPI Assessing Advanced RNA Nanoparticle Vaccine

Zika virus

An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine

Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

T-cells and cancer cells

A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes

Protein Chemistry Biotech Gains Collaboration, Venture Funds

DNA molecule model

An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds

Implanted Organoid Connects to Brain, Reacts to Visual Cues

Mature neuron

Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues

Peptide Discovery Company to Gain $3.3B in Licensing Deals

Test tubes in a lab

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

Food Protein Biotech Adds €4M in Seed Funds

Microscopic image of archaea

A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds. . . . → Read More: Food Protein Biotech Adds €4M in Seed Funds

Immune Organoid Company Raises $4.3M in Seed Funds

Microscopic image of lymph node tissue

A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds. . . . → Read More: Immune Organoid Company Raises $4.3M in Seed Funds

Trial Shows Gel Clears Common Skin Cancer Wounds

Cut ripe pineapple

Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors. . . . → Read More: Trial Shows Gel Clears Common Skin Cancer Wounds